Barth Syndrome Patients' Plea: FDA's Elamipretide Decision Sparks Despair

Understanding Barth Syndrome

• 💡 Barth Syndrome is an ultra-rare genetic disorder affecting approximately 150 Americans and under 300 worldwide, impacting the body from head to toe.
• 🎯 It primarily impairs heart functionality, the immune system, and the musculoskeletal system, often leading to a life-limiting or fatal outcome due to the lack of approved therapies.
• 🧬 The condition primarily affects males, though women can be carriers of the gene, and it can also occur de novo.

The Hope of Elamipretide

• 🚀 An experimental drug called Elamipretide offered a ray of hope for those with Barth Syndrome by targeting and restoring the function of mitochondria, the 'powerhouses' of cells.
• ✨ Patients who have taken the drug report life-changing improvements, including elimination of fatigue, increased strength, and a significantly better quality of life, with some regaining the ability to exercise.
• ⚠️ The drug is administered subcutaneously and works by restoring the proper shape and function of mitochondria, which are often malformed in individuals with Barth Syndrome.

FDA's Reconsideration Refusal and Its Impact

• 💔 In a significant blow, the FDA refused a request to reconsider the new drug application for Elamipretide in August 2025, prolonging the approval process.
• ⏳ The FDA has asked the drug's makers, Stealth Biootherapeutics, to resubmit for a third time, adding an estimated 6 months to a review process that has already exceeded 24 months for a small patient dataset.
• 📉 This decision has put the drug's availability at risk, as Stealth Biootherapeutics is facing rapidly dwindling funding and cannot guarantee continued drug supply or company sustainability.

Patient and Family Struggles

• 😥 Parents describe the immense challenge of caring for children with Barth Syndrome, including learning CPR, managing feeding tubes, and administering multiple daily medications.
• 😟 The prospect of losing access to Elamipretide means returning to a life of constant monitoring, debilitating symptoms, and the fear of the disease's progression.
• 🗣️ Patients and families are urging the public to contact their Congress members to encourage the FDA to approve Elamipretide, emphasizing that the drug is both effective and safe, as proven by their own lives.